MyTACTIC: Activity of targeted therapy in patients (pts) with advanced solid tumors harboring specific biomarkers

被引：0
|
作者：
Schwartzberg, Lee S.
Spigel, David R.
VanderWalde, Ari
Zuniga, Richard Michael
Hong, Jason
Szado, Tania
Yoo, Bongin
Passler, Luke
Wang, Yong
Darbonne, Walter C.
Daniel, Davey
机构：
[1] Renown Hlth Pennington Canc Inst, Reno, NV USA
[2] Sarah Cannon Res Inst, Nashville, TN USA
[3] West Canc Ctr & Res Inst, Clin Res, Germantown, TN USA
[4] OneOncol Inc, Nashville, TN USA
[5] Genentech Inc, US Med Affairs Oncol, South San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3100
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors: ARTISTRY-1
    Vaishampayan, Ulka N.
    Tomczak, Piotr
    Muzaffar, Jameel
    Winer, Ira Seth
    Rosen, Seth David
    Hoimes, Christopher J.
    Chauhan, Aman
    Spreafico, Anna
    Lewis, Karl D.
    Bruno, Debora S.
    Dumas, Olivier
    McDermott, David F.
    Strauss, James Fredric
    Chu, Quincy S.
    Gilbert, Lucy
    Chaudhry, Arvind
    Graham, Julie R.
    Boni, Valentina
    Ernstoff, Marc S.
    Velcheti, Vamsidhar
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Phase I trial with farnesyltransferase inhibitor R115777 in patients (pts) with advanced solid tumors
    Punt, CJA
    Peters, M
    van Maanen, L
    van de Walle, B
    Bol, C
    Willems, L
    Horak, I
    Palmer, P
    Wagener, DJT
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S291 - S291
  • [43] A phase I study of nab-paclitaxel in patients (pts) with advanced solid tumors and hepatic dysfunction
    Biakhov, M. Y.
    Kirsanov, D.
    Kononova, G.
    Loibl, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Phase I study of PM00104 in combination with carboplatin in patients (pts) with advanced solid tumors
    Calvo, Emiliano
    Gil, Marta
    Coronado, Cinthya
    Valer, Anna
    Duran, Ignacio
    Hidalgo, Manuel
    Pardo, Beatriz
    Calles, Antonio
    Garcia, Margarita
    Morelli, Pia
    Kahatt, Carmen
    Prados, Raquel
    Fernandez, Carlos
    Salazar, Ramon
    CANCER RESEARCH, 2012, 72
  • [45] The effect of motesanib treatment on the gallbladder: A randomized phase Ib study in patients (pts) with advanced solid tumors
    Tebbutt, N. C.
    Lipton, L. R.
    Price, T. J.
    Belman, N. D.
    Boccia, R. V.
    Hurwitz, H.
    Stephenson, J.
    Wirth, L. J.
    McCoy, S.
    Sikorski, R.
    Hei, Y. J.
    Rosen, L. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] A phase II open-label study in adult and adolescent patients (pts) with advanced solid tumors harboring fibroblast growth factor receptor (FGFR) gene alterations.
    Pant, Shubham
    Tabernero, Josep
    Massard, Christophe
    Iyer, Gopa
    Witt, Olaf
    Doi, Toshihiko
    Qin Shukui
    Lu-Emerson, Christine
    Hargrave, Darren R.
    Garcia-Corbacho, Javier
    Little, Shonda Marie
    Xia, Qi
    Santiago-Walker, Ademi E.
    Moy, Christopher
    Hammond, Constance
    Sweiti, Hussein
    Schuler, Martin H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [47] Developments in targeted therapy of advanced gastrointestinal stromal tumors
    Rutkowski, Piotr
    Symonides, Malgorzata
    Zdzienicki, Marcin
    Siedlecki, Janusz A.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2008, 3 (02) : 88 - 99
  • [48] Adoptive Cell Therapy for Advanced Solid Tumors
    Mullinax, John E.
    Pilon-Thomas, Shari
    CANCER JOURNAL, 2022, 28 (04): : 255 - 256
  • [49] Past, Present and Future of Targeted Therapy in Solid Tumors
    Palazzo, A.
    Iacovelli, R.
    Cortesi, E.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (05) : 433 - 461
  • [50] Panel Sequencing for Targeted Therapy Selection in Solid Tumors
    Willard, Nicholas
    Sholl, Lynette
    Aisner, Dara
    CLINICS IN LABORATORY MEDICINE, 2022, 42 (03) : 309 - 323
12345